News tagged with doxycycline
Doxycycline
Doxycycline INN ( /ˌdɒksɨˈsaɪkliːn/ doks-i-sy-kleen) is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. Doxycycline is a semisynthetic tetracycline invented and clinically developed in the early 1960s by Pfizer Inc.[citation needed] and marketed under the brand name Vibramycin.[citation needed] Vibramycin received U.S. Food and Drug Administration (FDA) approval in 1967,[citation needed] becoming Pfizer's first once-a-day, broad-spectrum antibiotic.[citation needed] Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx, Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral,Doxy-1 and Atridox (topical doxycycline hyclate for periodontitis).
For more information about Doxycycline, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Antibiotics cure anthrax in animal models
In the absence of early antibiotic treatment, respiratory anthrax is fatal. The 2001 bioterrorism attacks in the US killed four people, out of 22 infected (10 of them with respiratory anthrax), despite massive antibiotic ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 20, 2011 |
not rated yet |
0
New medical weapons to protect against anthrax attacks
The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any ...
Jun 23, 2010 |
not rated yet |
0
Before or after birth, gene linked to mental health has different effects
Scientists have long eyed mutations in a gene known as DISC1 as a possible contributor to schizophrenia and mood disorders, including depression and bipolar disorder. Now, new research led by Johns Hopkins researchers suggests ...
Medicine & Health / Psychology & Psychiatry
Jan 05, 2010 |
5 / 5 (2) |
0
|
New combination therapy looks promising against ulcer bacteria
Results of a new study reveal that a seven-day course of LOAD therapy is superior to LAC at eliminating the H. pylori bacterium in patients with gastritis and peptic ulcers.
Medicine & Health / Diseases, Conditions, Syndromes
Oct 26, 2009 |
1 / 5 (1) |
0
